Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginsenoside Rg3 Prevents Cognitive Impairment by Improving Mitochondrial Dysfunction in the Rat Model of Alzheimer’s Disease
Yan Zhang, Xiaomei Yang, Shuang Wang, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 36, pp. 10048-10058
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy
Hanbing Liu, Xiaoyan Lu, Yang Hu, et al.
Pharmacological Research (2020) Vol. 161, pp. 105263-105263
Open Access | Times Cited: 255
Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review
Wenqi Xu, Lyu Wei, Cuicui Duan, et al.
Fitoterapia (2023) Vol. 167, pp. 105514-105514
Closed Access | Times Cited: 31
Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer's disease via stimulation of the AMPK/Nrf2 signaling pathway
Lingyu She, Jinfeng Sun, Xiong Li, et al.
Phytomedicine (2023) Vol. 122, pp. 155168-155168
Open Access | Times Cited: 24
Recent trends in ginseng research
Honoka Ito, Michiho Ito
Journal of Natural Medicines (2024) Vol. 78, Iss. 3, pp. 455-466
Closed Access | Times Cited: 11
Neuroprotective Potentials of Panax Ginseng Against Alzheimer’s Disease: A Review of Preclinical and Clinical Evidences
Jing Li, Qingxia Huang, Jinjin Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 46
Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics
Jing Lu, Xian Wang, Anxin Wu, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 4, pp. 1523-1544
Closed Access | Times Cited: 31
Ginseng under forest exerts stronger anti-aging effects compared to garden ginseng probably via regulating PI3K/AKT/mTOR pathway, SIRT1/NF-κB pathway and intestinal flora
Mingqian Hao, Chuanbo Ding, Xiaojuan Peng, et al.
Phytomedicine (2022) Vol. 105, pp. 154365-154365
Closed Access | Times Cited: 30
Ginsenoside Rk3 ameliorates Aβ-induced neurotoxicity in APP/PS1 model mice via AMPK signaling pathway
Lingyu She, Xiong Li, Liwei Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114192-114192
Open Access | Times Cited: 28
Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease
Zeng-Ping Kang, Youbao Zhonga, Tiantian Wu, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 3, pp. 700-711
Open Access | Times Cited: 35
Traditional Chinese Medicine Intervenes in Vascular Dementia: Traditional Medicine Brings New Expectations
Xue Bai, Meng Zhang
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 35
Correction to “Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease”
Zhonghua Li, Zhenqiang Zhang, Bin Yu
Journal of Medicinal Chemistry (2025)
Closed Access
Roles of plant‐derived bioactive compounds and relatedmicroRNAsin cancer therapy
Heng Zou, Yanli Li, Xiaomin Liu, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 3, pp. 1176-1186
Closed Access | Times Cited: 35
Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in C. elegans Model of Parkinson’s Disease
Pawanrat Chalorak, Tanatcha Sanguanphun, Tanapol Limboonreung, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4843-4843
Open Access | Times Cited: 31
Effects and mechanisms of natural products on Alzheimer’s disease
Zhijun Yang, Dan-Dan Zhou, Siyu Huang, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 18, pp. 3168-3188
Closed Access | Times Cited: 30
Nanomedicine Based on Natural Products: Improving Clinical Application Potential
Zhe Li, Tingting Zhao, Jiaxin Li, et al.
Journal of Nanomaterials (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 21
Therapeutic Candidates for Alzheimer’s Disease: Saponins
Ruifeng Zhang, Miao Zeng, Xiaolu Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10505-10505
Open Access | Times Cited: 11
Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease
Shan He, Junhe Shi, Hua Chai, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26642-e26642
Open Access | Times Cited: 4
Ginsenoside Rg3 Restores Mitochondrial Cardiolipin Homeostasis via GRB2 to Prevent Parkinson's Disease
Li‐Feng‐Rong Qi, Shuai Liu, Qiuyuan Fang, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 4
Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease
Zhonghua Li, Zhenqiang Zhang, Bin Yu
Journal of Medicinal Chemistry (2025)
Closed Access
Korean Black Ginseng Extract Alleviates Alzheimer’s Disease-Related Cognitive Impairment by Activating the Nrf2/HO-1 Pathway and Suppressing the p38 MAPK/NF-κB/STAT3 Pathways and NLRP3 Inflammasome via TLR2 and TLR4 Modulation
Yujeong Ha, Hyo-Sung Jo, Tae Woo Kwon, et al.
Journal of Ginseng Research (2025)
Open Access
Ginseng in Delaying Brain Aging: Progress and perspectives
Jingwen Niu, Guoqi Zhu, Junjie Zhang
Phytomedicine (2025), pp. 156587-156587
Closed Access
Gentiopicroside prevents alcoholic liver damage by improving mitochondrial dysfunction in the rat model
Yan Zhang, Xiaomei Yang, Shuang Wang, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 4, pp. 2230-2251
Closed Access | Times Cited: 30
Review of ginsenosides targeting mitochondrial function to treat multiple disorders: Current status and perspectives
Qingxia Huang, Song Gao, Daqing Zhao, et al.
Journal of Ginseng Research (2020) Vol. 45, Iss. 3, pp. 371-379
Open Access | Times Cited: 26
Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease
Seong Lin Teoh, Ker Woon Choy, Kah-Hui Wong, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 8, pp. 1498-1518
Open Access | Times Cited: 19
Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer’s disease: A comprehensive review
Xin Jin, Jialing Guo, Lin Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 218, pp. 113401-113401
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top